M. Alt

517 total citations
11 papers, 438 citations indexed

About

M. Alt is a scholar working on Hepatology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M. Alt has authored 11 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Hepatology, 2 papers in Molecular Biology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M. Alt's work include Hepatitis C virus research (3 papers), Viral Infections and Immunology Research (2 papers) and Microbial infections and disease research (2 papers). M. Alt is often cited by papers focused on Hepatitis C virus research (3 papers), Viral Infections and Immunology Research (2 papers) and Microbial infections and disease research (2 papers). M. Alt collaborates with scholars based in Germany. M. Alt's co-authors include Ralph Grassmann, Bernhard Fleckenstein, Wolfgang H. Caselmann, Joseph Sodroski, Urban Ramstedt, William A. Haseltine, Susanne Berchtold, E Platzer, P. H. Hofschneider and Berthold Seitz and has published in prestigious journals such as Hepatology, Journal of Virology and Journal of General Virology.

In The Last Decade

M. Alt

11 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Alt Germany	7	270	204	198	107	76	11	438
Gallo Rc United States	8	204 0.8×	125 0.6×	108 0.5×	87 0.8×	82 1.1×	15	374
BRIAN HJELLE United States	8	261 1.0×	219 1.1×	196 1.0×	37 0.3×	21 0.3×	9	349
Amanda R. Panfil United States	12	235 0.9×	119 0.6×	111 0.6×	83 0.8×	159 2.1×	29	477
G Feuer United States	9	209 0.8×	123 0.6×	128 0.6×	30 0.3×	75 1.0×	13	345
Ulrich D. Kadolsky United Kingdom	7	212 0.8×	106 0.5×	95 0.5×	37 0.3×	82 1.1×	11	338
Yasuko Sagara Japan	10	633 2.3×	437 2.1×	407 2.1×	41 0.4×	54 0.7×	33	684
Joko Imai Japan	12	507 1.9×	417 2.0×	363 1.8×	37 0.3×	16 0.2×	25	613
Shigemasa Shioiri Japan	12	521 1.9×	419 2.1×	358 1.8×	45 0.4×	11 0.1×	17	576
Mengge Wu China	7	146 0.5×	76 0.4×	29 0.1×	50 0.5×	140 1.8×	9	381
Masateru Kohakura Japan	6	602 2.2×	481 2.4×	445 2.2×	22 0.2×	30 0.4×	6	711

Countries citing papers authored by M. Alt

Since Specialization

Citations

This map shows the geographic impact of M. Alt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Alt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Alt more than expected).

Fields of papers citing papers by M. Alt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Alt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Alt. The network helps show where M. Alt may publish in the future.

Co-authorship network of co-authors of M. Alt

This figure shows the co-authorship network connecting the top 25 collaborators of M. Alt. A scholar is included among the top collaborators of M. Alt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Alt. M. Alt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Alt, M., et al.. (1997). Core specific antisense phosphorothioate oligodeoxynucleotides as potent and specific inhibitors of hepatitis C viral translation. Archives of Virology. 142(3). 589–599. 17 indexed citations

2.

Guillemet, Cécile, et al.. (1997). [Clarithromycin-digoxin: an unrecognized interaction in some patients].. PubMed. 26(11). 512–512. 1 indexed citations

3.

Engels, J. W., et al.. (1997). Backbone Modified Antisense Oligodeoxynucleotides Directed Against the Hepatitis-C-Virus (HCV)-RNA. Nucleosides and Nucleotides. 16(7-9). 1669–1672. 1 indexed citations

4.

Caselmann, Wolfgang H. & M. Alt. (1996). Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma.. PubMed. 24(2 Suppl). 61–6. 60 indexed citations

5.

Alt, M., et al.. (1995). [Are nasal swabs for swine appropriate for the diagnosis of bacterial pneumonia agents?].. PubMed. 102(11). 427–30. 1 indexed citations

6.

Alt, M.. (1995). Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides*1. Hepatology. 22(3). 707–717. 15 indexed citations

7.

Alt, M., et al.. (1995). Specific inhibition of hepatitis C viral gene expression: Antisense phosphorothioate oligodeoxynucleotides. European Journal of Gastroenterology & Hepatology. 7(11). 1131–1132. 12 indexed citations

8.

Alt, M. & Ralph Grassmann. (1993). Resistance of human fibroblasts to c-fos mediated transformation.. PubMed. 8(6). 1421–7. 10 indexed citations

9.

Alt, M., et al.. (1993). [Comparison of EBL cells and ELISA in the culture and serological diagnosis of rhinitis atrophicans in swine].. PubMed. 100(3). 99–102. 1 indexed citations

10.

Grassmann, Ralph, Susanne Berchtold, M. Alt, et al.. (1992). Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture. Journal of Virology. 66(7). 4570–4575. 272 indexed citations

11.

Alt, M., et al.. (1991). Persistence of Selectable Herpesvirus Saimiri in Various Human Haematopoietic and Epithelial Cell Lines. Journal of General Virology. 72(8). 1953–1958. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact